Document:

Exhibit 10.1

STOCK PURCHASE AGREEMENT

This STOCK PURCHASE
AGREEMENT (the “Agreement”), dated as of March 22, 2013 by and among Clearview Medical, LLC, a Louisiana limited liability
company, (“CM” or “Seller”) with a principal place of business at 212 Edgewood Drive, Pineville, Louisiana
71360, Oncologix Tech, Inc.(“OCLG”) a Nevada corporation, with a principal place of business in Grand Rapids, MI, 49518
and a mailing address of PO Box 8832, Grand Rapids, MI 49518-8832 and Dotolo Research Corporation, a Florida corporation (“DRC”
or the “Company”) with an address of 3731 East LaSalle, Phoenix, AZ 85040.

 

W I T N E S S E T H:

WHEREAS, the Seller is the owner of
1,000 shares of common stock, par value $.01 per share, of DRC (the “Shares”) representing all the issued and outstanding
shares of DRC; and

 

WHEREAS, Seller desires
to sell, and OCLG desires to purchase, the Shares on the terms and conditions set forth herein;

NOW, THEREFORE, in
consideration of the mutual representations, warranties, agreements and indemnities herein contained and other good and valuable
consideration, the receipt and sufficiency of which is hereby mutually acknowledged, the parties agree as follows:

1.            Purchased
Shares

Subject to the terms
and conditions herein stated, CM hereby agrees to sell, assign, transfer and deliver to OCLG on the Closing Date, and OCLG hereby
agrees to purchase the Shares from Seller on the Closing Date, in exchange for 58,564 shares of a newly created series of preferred
stock (“New Preferred” and the shares of New Preferred to be issued to CM are hereinafter referred to as “New
Preferred Shares”) having the rights preferences and limitations to be set forth in the a certificate of designation attached
hereto as Exhibit 1. The New Preferred Shares shall be issued as soon as possible after the Closing Date, but no later than thirty
(30) days after the closing date. 

2.            Seller Employment.At
the Closing, OCLG shall execute an employment agreement with R. Wayne Erwin in the form attached as Exhibit 2 to this agreement.

3.            Closing
Date

The consummation of
the transactions contemplated by this Agreement (the “Closing”) shall take place on March 22, 2013 (the “Closing
Date”), at the offices of Seller in Pineville, Louisiana.

 

    	 

    	 

    

 

4.            Representations
and Warranties

4.1            By
Seller and DRC. Seller and DRC, jointly and severally, represent and warrant as follows and acknowledge that OCLG is relying
upon such representations and warranties in connection with the purchase by OCLG of the Shares:

	 	(a)	DRC is
a corporation duly incorporated, validly existing and in good standing under the laws of the State of Florida and in each jurisdiction
where its business or its ownership of property requires such qualification except where such failure to qualify would not have
a material adverse effect on the business or property of DRC;
		(b)	The authorized capital stock of DRC consists of 1,000 shares of common stock and 0 shares of preferred
stock; and of such authorized capital, only 1,000 shares of common stock have been duly issued and are outstanding, all of which
are fully paid and non-assessable;

		(c)	No person, corporation or other entity has any agreement, option or warrant, or any right or privilege
(whether by law, pre-emptive or contractual, or whether by means of any exercise, conversion or other right or action) which has
the effect of or is capable of becoming an agreement, option or warrant, for the purchase from DRC of any securities (including
convertible securities) of DRC;

		(d)	The Shares are owned by Seller and DRC as the respective registered and beneficial owner of record,
with good and marketable title thereto, free and clear of all mortgages, liens, charges, security interests, adverse claims, pledges,
encumbrances, restrictions and demands whatsoever (other than investment restrictions imposed by federal or state securities laws);

		(e)	No person, corporation or other entity has any agreement, option or warrant, or any right or privilege
(whether by law, pre-emptive or contractual, or whether by means of any exercise, conversion or other right or action) to acquire
any shares of DRC;

		(f)	Neither Seller nor DRC is party to, bound or affected by or subject to any indenture, mortgage,
lease, agreement, instrument, charter or by-law provision, statute, regulation, order, judgment, decree or law which would be violated,
contravened or breached by, or under which any default would occur as a result of, or which would prevent or materially restrict
the consummation of the transactions provided for herein;

		(g)	Seller and DRC have all requisite power and authority to execute, deliver and perform their obligations
under this Agreement; the execution, delivery and performance of this Agreement by Seller has been duly authorized by all necessary
action on the part of Seller and DRC; and this Agreement constitutes the legal, valid and binding obligation of Seller, enforceable
against them in accordance with its terms;

 

B-2

 

 

 

    	 

    	 

    

 

		(h)	None of the reports, notices, statements and other filings made by DRC to federal and state authorities
and as set forth in DRC’s financial statements as of August 31, 2012, contained any untrue statement of a material fact or
omitted to state a material fact necessary in order to make the statements contained therein not misleading. Nothing has occurred
since August 31, 2012 with respect to which the Company would be required to file or make any revisions to these Filings. The balance
sheets, statements of income, statements of cash flows, and stockholders’ equity have been prepared in accordance with generally
accepted accounting principles applied on a basis consistent with prior periods (and, in the case of unaudited financial information,
on a basis consistent with year-end audits); and without limitation of the foregoing, DRC has no material liabilities, fixed or
contingent, known or unknown, except to the extent reflected in such financial statements or thereafter incurred in the ordinary
course of business.

		(i)	Within 75 days of the Closing Date, the financial statements required by Item 9.01 of Form 8-K
shall be filed with the SEC. These financial statements shall be prepared pursuant to Regulation S-X and include a manually signed
accountant’s report pursuant to Rule 2-02 of Regulation S-X.

		(j)	Since August 31, 2012, (i) the business of DRC has been operated in the ordinary course, (ii) there
has been no material adverse change in the financial condition, operations or business of DRC from that reflected in the aforesaid
financial statements, and DRC has not incurred any material obligation or liability except in the ordinary course of business,
and, except as set forth on Exhibit 4.1(j) hereof, (iii) there has not been any (A) declaration, setting aside the payment of any
dividend or other distribution with respect to the capital stock of DRC, (B) direct or indirect redemption, purchase or other acquisition
by DRC of any of its capital stock, or (C) increase in the rate of salary or compensation paid or payable by DRC to Seller or any
other officer, director or employee of DRC;

		(k)	DRC is not in material default of any of its obligations (including, but not limited to, all leases
to which DRC is a party or by which DRC is bound, whether for realty or personalty);

		(l)	DRC has, to the date hereof, filed all federal, state and local tax returns and paid or made adequate
reserve on its books for all taxes, assessments and other impositions as and to the extent required by law;

		(m)	DRC is in compliance in all material respects with all laws, statutes, regulations, rules and ordinances
applicable to the conduct of its business, and has in full force and effect all licenses, permits and other authorizations required
for the conduct of its business as presently constituted;

B-3

 

 

    	 

    	 

    

 

 

		(n)	Intentionally left blank.

		(o)	DRC maintains, has in full force and effect, and has paid all premiums in respect of insurance
covering its business and assets against such hazards and in such amounts as are normal and customary for similar businesses of
similar size in the locality;

		(p)	DRC is not a party to or bound by any collective bargaining agreement, employment agreement, consulting
agreement or other commitment for the employment or retention of any person;

		(q)	DRC does not maintain and is not required to make any contributions to any pension, profit-sharing,
retirement, deferred compensation or other such plan or arrangement for the benefit of any employee, former employee or other person;

		(r)	There is no pending or, to Seller’ knowledge, threatened litigation, arbitration, administrative
proceeding or other legal action or proceeding against or relating to DRC’s business, nor is there any basis therefore except
as set forth in 4.1(r);

		(s)	DRC has the valid right to utilize all trade names, trademarks, patents, trade secrets and other
intellectual property utilized in its business, all of which is detailed in Exhibit 4.1 (s), and has not received notice of any
claimed infringement of any such intellectual property with the rights or property of any other person;

		(t)	Neither Seller nor DRC have any knowledge of any fact, event, circumstance or condition that would
materially impair DRC’s ability to continue its normal operations as heretofore conducted (other than general, industry-wide
conditions); and

		(u)	Annexed hereto as Exhibit 4.1(u) are true, complete and correct copies of the Articles of Incorporation
and By Laws of DRC as same are in effect now and which, Seller and DRC hereby covenant, will be in effect at the Closing without
any further amendments (unless agreed to in advance in writing by OCLG).

		(v)	Brokers or Finders. Neither the Seller nor DRC has incurred any obligation or liability,
contingent or otherwise, for brokerage or finders’ fees or agents’ commissions or financial advisory services nor other
similar payment in connection with this Agreement or the transactions contemplated hereby or thereby.

 

		(w)	Disclosure. No representation or warranty by the Seller contained in this Agreement or any
other Transaction Documents to which the Seller is a party, nor any written statement or certificate furnished by the Seller to
the OCLG or its representatives in connection herewith or therewith or pursuant hereto or thereto contains any untrue statement
of a material fact, or omits to state any material fact required to make the statements contained herein or therein not misleading.

 

B-4

 

 

    	 

    	 

    

 

 

		(x)	Books and Records. The books of account and other records of the Company, all of which have
been made available to OCLG, are true and correct. The Seller have provided OCLG with all written records of all meetings held
by, and corporate or limited liability DRC action taken by, the shareholders, the board of directors, committees of the board of
directors or the manager(s) and/or members of the Company. The stock books or equivalent records of the Seller and DRC are true,
complete and correct. As of the date hereof, all of such books and records are in the possession of the Seller and the Company.
True, complete and correct copies of the minute books, stock books or equivalent records of DRC have been provided to OCLG
	 	 	 
	 	(y)	Financial
                                                                                                                             Statements;
                                                                                                                             Undisclosed
                                                                                                                             Liabilities.
	 	 	 
	 	 	Within 75 days of the Closing Date,
the financial statements required by Item 9.01 of Form 8-K shall be filed with the SEC. These financial statements shall be prepared
pursuant to Regulation S-X and include a manually signed accountant’s report pursuant to Rule 2-02 of Regulation S-X. The
Financial Statements were prepared in accordance with GAAP during the period covered thereby, are in accordance with the books
and records of DRC and fairly and accurately present the financial position of DRC on the date of such statements and the results
of the operations of DRC for the period covered thereby. DRC does not have any known liabilities (absolute, accrued, contingent
or otherwise), except liabilities (i) reflected in the Financial Statements, (ii) incurred since the date of the Financial Statements,
in the ordinary course of business consistent with past practice, which are of the same general nature and amount as those set
forth on the face of the Financial Statements, other than any liabilities resulting from, arising out of, relating to, in the nature
of, or caused by any breach of contract, breach of warranty, tort, infringement or violation of law, in each case as otherwise
disclosed herein, or incurred in connection with this Agreement.

 

(z)          Accounts Receivable.
All accounts receivable of DRC that are reflected on the Financial Statements or on the accounts receivable ledger of the DRC as
of the date hereof (collectively, the “Accounts Receivable”) represent valid obligations arising from sales actually
made in the ordinary course of business.

 

(aa)          Title to Properties; Encumbrances.
DRC has good and merchantable title to all of the assets which they purport to own, whether reflected on the Financial Statements
or acquired subsequent to March 22, 2013, free and clear of all encumbrances and (ii) the DRC has the right to use all properties
and assets used by it which it does not purport to own, free and clear of all encumbrances. All real property, machinery, equipment,
fixtures, vehicles and other properties, tangible or intangible, which are owned, leased, licensed or used by the DRC are in good
operating condition and repair, ordinary wear and tear accepted.

 

B-5

 

 

    	 

    	 

    

 

 

(bb)          Condition and Sufficiency
of Assets. The assets owned or used by the DRC, including, without limitation, all inventories, are adequate for the uses to
which they are being put and sufficient for the continued conduct of its business after the date hereof in substantially the same
manner as conducted prior to the date hereof.

 

(cc)          Absence of Certain Changes
and Events. Since August 31, 2012, there has been (i) no material adverse change in the condition (financial or otherwise)
of DRC or in the business, operations, financial condition, assets, liabilities, prospects or contractual rights of the Company,
(ii) no declaration, setting aside or payment of any dividend or other distribution with respect to, or any direct or indirect
redemption or acquisition of, any of the capital stock of the DRC(iii) no material waiver of any valuable right of the DRC or cancellation
of any debt or claim held by the Company, (iv) no loan by DRC to any officer, director, employee or shareholder of the Company,
or any agreement or commitment therefor, (v) other than in the ordinary course of business, no material increase, direct or indirect,
in the compensation paid or payable to any officer, director, employee or agent of the Company, (vi) no material loss, destruction
or damage to any property of the DRC whether or not insured, (vii) no material change in the personnel of the DRC or the terms
and conditions of their employment, (viii) no acquisition or disposition of any assets (or any contract or arrangement therefor),
nor any other transaction by the DRC otherwise than for fair value in the ordinary course of business consistent with past practice,
(ix) no material change in election, annual accounting period or accounting period, no amendment to any tax return, no settlement
of any tax claim or assessment, no surrender of any right to claim a refund, no consent to any extension or waiver of the limitation
period applicable to any Tax claim or assessment and (x) no contract, agreement, commitment, expenditure or hiring of new employees
or consultants involving a potential commitment in excess of $5,000 or which is otherwise material and not entered into in the
ordinary course of business consistent with past practice.

 

(dd)          Contracts

 

(i)          Exhibit 4.1(dd) contains
a list of all contracts which: (i) involve the Company; (ii) involve monetary commitments by any party in excess of $5,000 and
(iii) cannot be canceled without penalty on thirty (30) days notice or less. Seller has provided true and correct copies of all
such contracts to OCLG, or, if applicable, summaries of any oral contracts.

 

(ii)          All the contracts listed in
Exhibit 4.1(dd) are valid and binding obligations of Seller or the Company, and, to Seller’s knowledge, of the other
party or parties thereto, enforceable against Seller or the Company, and, to Seller’s knowledge, of the other party or parties
thereto, except as enforcement thereof may be limited by bankruptcy, insolvency, moratorium or other similar laws affecting the
enforcement of creditor’s rights in general, or by general principles of equity.

 

B-6

 

 

    	 

    	 

    

 

 

(iii)          There has been no uncured
material breach or default in any provision of any of such contracts listed in Exhibit 4.1(dd) by the Seller or the DRC
or, to the Seller’s knowledge, any other party or parties thereto, and nothing has occurred which the lapse of time or giving
of notice or both would constitute an uncured material breach or default by the Seller or the DRC or, to the Seller’s knowledge,
any other party or parties thereto.

 

(ee)          Insurance. Exhibit
4.1(ee) lists all the insurance policies of the Company, which policies are now in full force and effect in accordance with
their terms and expire on the dates shown on Exhibit 4.1(ee). There has been no default in the payment of premiums on any
of such policies and, to the Seller’ knowledge, there is no ground for cancellation or avoidance of any such policies or
any increase in the premiums thereof, or for reduction of the coverage provided thereby. True, correct and complete copies of all
insurance policies listed in Exhibit 4.1(ee) will be furnished to the Buyer.

(ff)          Environmental
Matters. No event has occurred or condition exists or operating practice is being employed that under current law DRC is aware
of that could give rise to liability on the part of the Company, either at the present time or in the future, for any losses, liabilities,
damages (whether consequential or otherwise), settlements, penalties, interest and expenses (including any such liability on account
of the right of any governmental or private entity or person, and including closure expenses, costs of assessment, containment,
or removal), arising under any presently enacted federal, state, or local statute, or any regulation that has been promulgated
pursuant thereto, or common law, as a result of or in connection with, or alleged to be as a result of or in connection with, the
presence, handling, storage, use, transportation, disposal, treatment, discharge and/or release of any Substances in or near or
from facilities used by the Company. As used in this Section (ff) the term “Substances” shall mean any pollutant,
hazardous substance, hazardous material, hazardous waste or toxic waste, as defined in any presently enacted federal, state or
local statute or any regulation that has been promulgated pursuant thereto.

 

(gg)          Employee
Benefits. Except as set forth on Exhibit 4.1(gg), DRC does not, directly or through any trade or business which together
with Seller would be treated as a “single employer” within the meaning of Code Section 414(b), (c), (m) or (o) (“Controlled
Group Member”), maintain or contribute (or have an obligation to contribute) to (i) any “employee benefit plan”
(as defined in Section 3(3) of ERISA, whether a single employer, a multiple employer or a multiemployer plan, for the benefit of
employees or former employees, or (ii) any other plan, policy, program, practice or arrangement providing compensation or benefits
under which Seller or a Controlled Group Member has any obligation or liability to any employee or former employee (or any dependent
or other beneficiary thereof) including, without limitation, incentive, bonus, deferred compensation, vacation, holiday, medical,
severance, disability, death, stock purchase or other similar benefit, whether written or unwritten (individually, an “Employee
Benefit Plan” and collectively, the “Employee Benefit Plans”). True and complete copies of all written Employee
Benefit Plans have been delivered to OCLG.

 

B-7

 

 

    	 

    	 

    

 

 

(ii)           Each
Employee Benefit Plan maintained by DRC or any Controlled Group Member (and each related trust, custodial account or insurance
contract) complies in form and in operation with all applicable governmental requirements, including ERISA and the Code, except
where failure to comply would not have a material adverse effect, and all contributions due under each such plan have been or will
be made by the date such contribution is or was required to be made under the terms of the Plan or applicable law.

 

(iii)           No
charge, complaint, action, claim or demand with respect to the administration or investment of the assets of any Employee Benefit
Plan of DRC or any Controlled Group Member (other than routine claims for benefits) is pending or, to Seller’ knowledge,
threatened, and to the knowledge of Seller, no facts exist that could form the basis for any such charge, complaint, action, suit,
proceeding, hearing, investigation, claim or demand.

 

(iv)           DRC
and its Controlled Group Members (A) have never contributed to, or been under any obligation to contribute to, any multiemployer
plan (as defined in Section 3(37) of ERISA) and (B) are not liable, directly or indirectly, with respect to any such plan for a
complete or partial withdrawal (within the meaning of Title IV of ERISA) or due to the termination or reorganization of such a
plan. Seller and its Controlled Group Members have never maintained or contributed, or had an obligation to contribute, to a defined
benefit plan subject to Title IV of ERISA.

 

(hh)          Suppliers;
Customers.

 

Exhibit 4.1(hh) sets forth for
the twelve months ended August 31, 2012, (i) the names of the ten largest suppliers of DRC based on the aggregate value of merchandise
ordered by the DRC from such suppliers during such period and (ii) the amount for which each such supplier invoiced the DRC during
such period. No such supplier has ceased doing business with the Company. To Seller’ knowledge all such suppliers will sell
merchandise to DRC after Closing. Exhibit 4.1(hh) sets forth (i) a true, complete and correct listing of the ten largest
customers of DRC based upon the amount for which each such customer was invoiced during the twelve months ended August 31, 2012,
and (ii) a listing of such amounts. No such customer of the DRC has ceased doing business with DRC. To Seller’ knowledge,
all such customers will continue doing business with the DRC after Closing.

 

B-8

 

 

    	 

    	 

    

 

(ii)          Inventories.

 

All inventories of DRC are of good,
usable and merchantable quality and do not include obsolete or discontinued items. There are adequate reserves to cover any potential
obsolete inventory. All such inventories are of such quality as to meet the quality control standards of DRC and any applicable
governmental quality control standards, all such finished goods are saleable as current inventories at the current prices of DRC
in the ordinary course of business, all such inventories are recorded on the books at the lower of cost or market value determined
in accordance with GAAP.

 

(jj)          Product Warranties; Customer
Disputes. The Seller has provided OCLG with a copy of the Company’s standard terms of sale. Since January 1, 2013 there
have been no changes to DRC’s standard product warranties or any claims or complaints for defective products outside the
normal course of business.

4.2          By OCLG.
OCLG represents and warrants to Seller and DRC as follows and acknowledges that Seller and DRC are relying upon such representations
and warranties in connection with the sale by Seller of the Shares:

		(a)	OCLG is a company validly existing and in good standing under the laws of the State of Nevada and
in each jurisdiction where its business or its ownership of property requires such qualification except where such failure to qualify
would not have a material adverse effect on the business or property of OCLG;

		(b)	OCLG has all requisite power and authority to execute, deliver and perform its obligations under
this Agreement; the execution, delivery and performance of this Agreement by OCLG has been duly authorized by all necessary action
on the part of OCLG; and this Agreement constitutes the legal, valid and binding obligation of OCLG, enforceable against OCLG in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy or insolvency statutes or by a court
acting as a court of equity;

		(c)	OCLG is not a party to, bound or affected by or subject to any indenture, mortgage, lease, agreement,
instrument or charter provision, statute, regulation, order, judgment, decree or law which would be violated, contravened or breached
by, or under which any default would occur as a result of, the consummation of the transactions provided for herein; and

		(d)	OCLG is purchasing the Shares for its own account for investment purposes.

		(e)	As of March 22, 2013, the authorized capital stock of OCLG consists of 200,000,000 shares of common
stock and 10,000,000 shares of preferred stock; and of such authorized capital, only 61,587,422 shares of common stock and 129,162
shares of Series A Preferred Stock all of which have been duly issued and are validly outstanding fully paid and non-assessable;

B-9

 

 

    	 

    	 

    

 

 

		(f)	No person, corporation or other entity has any agreement, option or warrant, or any right or privilege
(whether by law, pre-emptive or contractual, or whether by means of any exercise, conversion or other right or action) which has
the effect of or is capable of becoming an agreement, option or warrant, for the purchase from OCLG of any securities (including
convertible securities) of OCLG which has not been disclosed in the footnotes to the financial statements included in OCLG’s
Form 10-Q for the period ending November 30, 2012 (the “10-Q”);

		(g)	The New Preferred Shares will, upon issuance, be duly issued and outstanding fully paid and non-assessable
shares of New Preferred;

		(h)	Except as disclosed in the 10-Q, no person, corporation or other entity has any agreement, option
or warrant, or any right or privilege (whether by law, pre-emptive or contractual, or whether by means of any exercise, conversion
or other right or action) which with the giving of notice or lapse of time could become an agreement, option or warrant, for the
purchase of any of the Shares;

		(i)	None of the reports, notices, statements and other filings made by OCLG to federal and state authorities
and as set forth in OCLG’S financial statements as of November 30, 2012, as included in the 10-Q or the financial statements
included OCLG’s Annual Report on Form 10-K for the year ended August 31, 2012 (the 10-K), contained any untrue statement
of a material fact or omitted to state a material fact necessary in order to make the statements contained therein not misleading.
Nothing has occurred since November 30, 2012 with respect to which the Company would be required to file or make any revisions
to the 10-Q. The balance sheets and statements of income, changes in financial position and stockholders’ equity contained
in any of the 10-Q and 10-K have been prepared in accordance with generally accepted accounting principles applied on a basis consistent
with prior periods (and, in the case of unaudited financial information, on a basis consistent with year-end audits); and without
limitation of the foregoing, OCLG has no material liabilities, fixed or contingent, known or unknown, except to the extent reflected
in such financial statements or thereafter incurred in the ordinary course of business.

		(j)	Since November 30, 2012, (i) the business of OCLG has been operated in the ordinary course, (ii)
there has been no material adverse change in the financial condition, operations or business of OCLG from that reflected in the
aforesaid financial statements, and OCLG has not incurred any material obligation or liability except in the ordinary course of
business, and, except as set forth on Exhibit 4.2(j) hereof, (iii) there has not been any (A) declaration, setting aside the payment
of any dividend or other distribution with respect to the capital stock of OCLG, (B) direct or indirect redemption, purchase or
other acquisition by OCLG of any of its capital stock, or (C) increase in the rate of salary or compensation paid or payable by
OCLG to Seller or any other officer, director or employee of OCLG;

B-10

 

 

    	 

    	 

    

 

 

		(k)	OCLG is not in material default of any of its obligations (including, but not limited to, all leases
to which OCLG is a party or by which OCLG is bound, whether for realty or personalty);

		(l)	OCLG has, to the date hereof, filed all federal, state and local tax returns and paid or made adequate
reserve on its books for all taxes, assessments and other impositions as and to the extent required by law;

		(m)	OCLG is in compliance in all material respects with all laws, statutes, regulations, rules and
ordinances applicable to the conduct of its business, and has in full force and effect all licenses, permits and other authorizations
required for the conduct of its business as presently constituted;

		(n)	OCLG maintains, has in full force and effect, and has paid all premiums in respect of insurance
covering its business and assets against such hazards and in such amounts as are normal and customary for similar businesses of
similar size in the locality;

		(o)	OCLG is not a party to or bound by any collective bargaining agreement, employment agreement, consulting
agreement or other commitment for the employment or retention of any with the exception of an Employment Agreement with the OCLG
Chief Financial Officer as defined in Exhibit 4.2(o).

		(p)	OCLG does not maintain and is not required to make any contributions to any pension, profit-sharing,
retirement, deferred compensation or other such plan or arrangement for the benefit of any employee, former employee or other person

		(q)	There is no pending or, to OCLG’S knowledge, threatened litigation, arbitration, administrative
proceeding or other legal action or proceeding against or relating to OCLG or its business;

		(r)	OCLG has the valid right to utilize all trade names, trademarks, patents, trade secrets and other
intellectual property utilized in its business, all of which is detailed in the 10-Q, and has not received notice of any claimed
infringement of any such intellectual property with the rights or property of any other person;

B-11

 

 

    	 

    	 

    

 

 

		(t)	OCLG has no knowledge of any fact, event, circumstance or condition that would materially impair
OCLG’S ability to continue its normal operations as heretofore conducted (other than general, industry-wide conditions);

		(u)	Annexed hereto as Exhibit 4.2(u) are true, complete and correct copies of the Articles of Incorporation
and By Laws of OCLG as same are in effect now and which, Seller and OCLG hereby covenant, will be in effect at the Closing without
any further amendments (unless agreed to in advance in writing by OCLG).

		(v)	Brokers or Finders. OCLG has not incurred any obligation or liability, contingent or otherwise,
for brokerage or finders’ fees or agents’ commissions or financial advisory services or other similar payment in connection
with this Agreement or the transactions contemplated hereby or thereby.

 

		(w)	Disclosure. No representation or warranty by the OCLG contained in this Agreement or any
other Transaction Documents to which the OCLG is a party, nor any written statement or certificate furnished by the OCLG to the
Seller or its representatives in connection herewith or therewith or pursuant hereto or thereto contains any untrue statement of
a material fact, or omits to state any material fact required to make the statements contained herein or therein not misleading.

 

		(x)	Books and Records. The books of account and other records of OCLG, all of which have been
made available to Seller are true and correct. OCLG has provided Seller with all written records of all meetings held by and corporate
or limited liability OCLG action taken by, the shareholders, the board of directors, committees of the board of directors or the
manager(s) and/or members of the Company. The stock books or equivalent records of OCLG are true, complete and correct. As of the
date hereof, all of such books and records are in the possession of the Seller. True, complete and correct copies of the minute
books, stock books or equivalent records of OCLG have been provided to Seller;

 

 

(y)          Title
to Properties; Encumbrances. OCLG has good and merchantable title to all of the assets which they purport to own, whether reflected
in the 10-Q or acquired subsequent to November 30, 2012, free and clear of all encumbrances and (ii) OCLG has the right to use
all properties and assets used by it which it does not purport to own, free and clear of all encumbrances. All real property, machinery,
equipment, fixtures, vehicles and other properties, tangible or intangible, which are owned, leased, licensed or used by OCLG are
in good operating condition and repair, ordinary wear and tear.

 

B-12

 

 

    	 

    	 

    

 

 

(z)          Condition and Sufficiency
of Assets. The assets owned or used by the OCLG, including, without limitation, all inventories, are adequate for the uses
to which they are being put and sufficient for the continued conduct of its business after the date hereof in substantially the
same manner as conducted prior to the date hereof.

 

(aa)          Absence of Certain Changes
and Events. Since November 30, 2012, there has been (i) no material adverse change in the condition (financial or otherwise)
of OCLG or in the business, operations, financial condition, assets, liabilities, prospects or contractual rights of OCLG, (ii)
no declaration, setting aside or payment of any dividend or other distribution with respect to, or any direct or indirect redemption
or acquisition of, any of the capital stock of the OCLG (except for the dividends in the purview of Section 8 hereof), (iii) no
material waiver of any valuable right of the OCLG or cancellation of any debt or claim held by the Company, (iv) no loan by OCLG
to any officer, director, employee or shareholder of the Company, or any agreement or commitment therefor, (v) other than in the
ordinary course of business, no material increase, direct or indirect, in the compensation paid or payable to any officer, director,
employee or agent of the Company, (vi) no material loss, destruction or damage to any property of the OCLG whether or not insured,
(vii) no material change in the personnel of the OCLG or the terms and conditions of their employment, (viii) no acquisition or
disposition of any assets (or any contract or arrangement therefor), nor any other transaction by the OCLG otherwise than for fair
value in the ordinary course of business consistent with past practice, (ix) no material change in election, annual accounting
period or accounting period, no amendment to any tax return, no settlement of any tax claim or assessment, no surrender of any
right to claim a refund, no consent to any extension or waiver of the limitation period applicable to any Tax claim or assessment
and (x) no contract, agreement, commitment, expenditure or hiring of new employees or consultants involving a potential commitment
in excess of $5,000 or which is otherwise material and not entered into in the ordinary course of business consistent with past
practice.

 

(bb)          Contracts

Exhibit 4.2(bb) contains a list
of all contracts which: (i) involve the Company; (ii) involve monetary commitments by any party in excess of $5,000 and (iii) cannot
be canceled without penalty on thirty (30) days notice or less. OCLG has provided true and correct copies of all such contracts
to Seller, or, if applicable, summaries of any oral contracts.

 

(ii)          All the contracts listed in
Exhibit 4.2(bb) are valid and binding obligations of OCLG, and, to OCLG’s knowledge, of the other party or parties
thereto, enforceable against OCLG, and, to OCLG’s knowledge, of the other party or parties thereto, except as enforcement
thereof may be limited by bankruptcy, insolvency, moratorium or other similar laws affecting the enforcement of creditor’s
rights in general, or by general principles of equity.

  

B-13

 

 

    	 

    	 

    

 

 

(iii)          There has been no uncured
material breach or default in any provision of any of such contracts listed in Exhibit 4.2(bb) by OCLG or, to OCLG’s
knowledge, any other party or parties thereto, and nothing has occurred which the lapse of time or giving of notice or both would
constitute an uncured material breach or default by OCLG or, to OCLG’s knowledge, any other party or parties thereto.

 

(cc)          Insurance. Exhibit
4.2(cc) lists all the insurance policies of OCLG, which policies are now in full force and effect in accordance with their
terms and expire on the dates shown on Exhibit 4.2(cc), together with such information for the period from December 1, 2012
to the present with respect to any claims thereunder. There has been no default in the payment of premiums on any of such policies
and, to OGLC’s knowledge, there is no ground for cancellation or avoidance of any such policies or any increase in the premiums
thereof, or for reduction of the coverage provided thereby. True, correct and complete copies of all insurance policies listed
in Exhibit 4.2 (cc) will be furnished to the Seller.

(dd)          Environmental
Matters. No event has occurred or condition exists or operating practice is being employed that under current law OCLG is aware
of that could give rise to liability on the part of OCLG, either at the present time or in the future, for any losses, liabilities,
damages (whether consequential or otherwise), settlements, penalties, interest and expenses (including any such liability on account
of the right of any governmental or private entity or person, and including closure expenses, costs of assessment, containment,
or removal), arising under any presently enacted federal, state, or local statute, or any regulation that has been promulgated
pursuant thereto, or common law, as a result of or in connection with, or alleged to be as a result of or in connection with, the
presence, handling, storage, use, transportation, disposal, treatment, discharge and/or release of any Substances in or near or
from facilities used by the Company. As used in this Section (dd) the term “Substances” shall mean any pollutant,
hazardous substance, hazardous material, hazardous waste or toxic waste, as defined in any presently enacted federal, state or
local statute or any regulation that has been promulgated pursuant thereto.

 

(ee)Employee
Benefits.

(i)           OCLG
does not, directly or through any trade or business which together with Seller would be treated as a “single employer”
within the meaning of Code Section 414(b), (c), (m) or (o) (“Controlled Group Member”), maintain or contribute (or
have an obligation to contribute) to (i) any “employee benefit plan” (as defined in Section 3(3) of ERISA, whether
a single employer, a multiple employer or a multiemployer plan, for the benefit of employees or former employees, or (ii) any
other plan, policy, program, practice or arrangement providing compensation or benefits under which Seller or a Controlled Group
Member has any obligation or liability to any employee or former employee (or any dependent or other beneficiary thereof) including,
without limitation, incentive, bonus, deferred compensation, vacation, holiday, medical, severance, disability, death, stock purchase
or other similar benefit, whether written or unwritten (individually, an “Employee Benefit Plan” and collectively,
the “Employee Benefit Plans”). True and complete copies of all written Employee Benefit Plans have been delivered
to Seller.

B-14

 

    	 

    	 

    

(ii)           Each
Employee Benefit Plan maintained by OCLG or any Controlled Group Member (and each related trust, custodial account or insurance
contract) complies in form and in operation with all applicable governmental requirements, including ERISA and the Code, except
where failure to comply would not have a material adverse effect, and all contributions due under each such plan have been or will
be made by the date such contribution is or was required to be made under the terms of the Plan or applicable law.

(iii)           No
charge, complaint, action, claim or demand with respect to the administration or investment of the assets of any Employee Benefit
Plan of OCLG or any Controlled Group Member (other than routine claims for benefits) is pending or, to Seller’ knowledge,
threatened, and to the knowledge of Seller, no facts exist that could form the basis for any such charge, complaint, action, suit,
proceeding, hearing, investigation, claim or demand.

(iv)           OCLG
and its Controlled Group Members (A) have never contributed to, or been under any obligation to contribute to, any multiemployer
plan (as defined in Section 3(37) of ERISA) and (B) are not liable, directly or indirectly, with respect to any such plan for a
complete or partial withdrawal (within the meaning of Title IV of ERISA) or due to the termination or reorganization of such a
plan. Seller and its Controlled Group Members have never maintained or contributed, or had an obligation to contribute, to a defined
benefit plan subject to Title IV of ERISA.

 

(ff)          Suppliers;
Customers.

 

For the twelve months ended August
31, 2012, OCLG has had no suppliers or customers.

 

(gg)          Inventories.

 

OCLG maintains no inventories.

 

		(hh)	Product Warranties; Customer Disputes. The OCLG has provided Seller with a copy of the Company’s
standard terms of sale. Since August 31, 2012 there have been no changes to OCLG’s standard product warranties or any claims
or complaints for defective products.

		(ii)	OCLG is not and has never been a “Shell company” as that term is defined in Rule 405
under the Securities Act of 1933, as amended and any published interpretations of such term by the Securities and Exchange Commission
(“SEC”).

		(jj)	The periodic and current reports filed with the SEC by OCLG pursuant to the SEC under the Securities
Exchange Act of 1934, as amended, were true accurate and complete when filed and do not fail to state any fact necessary in order
to make the statements therein not misleading.

 

B-15

 

    	 

    	 

    

 

5.          Survival
of Representations and Warranties

5.1          Seller.
The representations and warranties of Seller contained in this Agreement, or any agreement, certificate or other document delivered
or given pursuant to this Agreement, shall survive the consummation of the transactions contemplated by this Agreement and, notwithstanding
such completion or any investigation made by or on behalf of OCLG, shall continue in full force and effect for the benefit of OCLG
and any claim in respect thereof shall be made in writing:

		(a)	with respect to representations and warranties of Seller, relating to matters other than tax matters,
for a period of 18 months after the Closing Date; and

		(b)	with respect to representations and warranties of Seller, relating to tax liability or other tax
matters, within the period commencing on the Closing Date and expiring on the date on which the last applicable limitation period
(without giving effect to any voluntary extension(s) hereafter granted by or on behalf of DRC) under any applicable taxation legislation
expires with respect to any fiscal year of DRC which is relevant in determining any relevant tax liability of DRC.

5.2          OCLG.
The representations and warranties of OCLG contained in this Agreement, or any agreement, certificate or other document delivered
or given pursuant to this Agreement, shall survive the completion of the transactions contemplated by this Agreement and, notwithstanding
such completion or any investigation made by or on behalf of Seller, shall continue in full force and effect for the benefit of
Seller and any claim in respect thereof shall be made in writing for a period of 18 months after the Closing Date.

5.3          General.
The provision of this Section 5 respecting the expiration of claims periods is expressly subject to Section 10.3 hereof.

6.          [INTENTIONALLY
LEFT BLANK] 

7.          Additional
Agreements

Each of Seller
and OCLG shall take or cause to be taken all necessary or desirable actions, steps and corporate proceedings to approve or authorize
the transactions contemplated by this Agreement and the execution and delivery of this Agreement and other agreements, understandings
and documents contemplated hereby, and shall cause all necessary meetings of directors and stockholders to be held for such purpose.

B-16

 

 

    	 

    	 

    

8.                 
Deliveries and Conditions Precedent to Closing 

8.1             
Conditions Precedent to the Obligation of OCLG. The obligation of OCLG to complete the transactions contemplated
herein is subject to the satisfaction of, or compliance with, on or before the Closing Date, each of the following conditions (each
of which is acknowledged to be for the exclusive benefit of OCLG and may be waived by it in whole or in part):

(a)               
Completion of due diligence review to its reasonable satisfaction by March 22, 2013;

(b)              
The representations and warranties of Seller contained herein shall be true and correct as at the Closing Date to the best
of their knowledge;

(c)               
Seller shall have performed all of their obligations under this Agreement to be performed by them on or prior to the Closing
Date and Seller shall not be in breach of any agreement on their part contained in this Agreement;

(d)              
All documents relating to the due authorization and completion of the transactions contemplated hereby and all actions and
proceedings taken on or prior to the Closing Date in connection with the performance by Seller of their obligations under this
Agreement shall be satisfactory to OCLG and its counsel and OCLG shall have received copies of all such documents or other evidence
as it may reasonably request in form and substance satisfactory to OCLG and its counsel and its counsel;

 

(e)
           
Receipt of necessary approvals by the state or local authorities, as needed; 

(f)               Review
of the DRC internal GAAP financial statements for the year ended August 31, 2011 and at August 31, 2012 in a manner and with results
reasonably satisfactory to OCLG.

8.2             
Conditions Precedent to Obligations to Seller. The obligation of Seller to complete the transactions contemplated
hereunder is subject to the satisfaction of, or compliance with, on or before the Closing Date, each of the following conditions
(each of which is acknowledged to be for the exclusive benefit of Seller and may be waived by them in whole or in part):

(a)               
the representations and warranties of OCLG contained herein shall be true and correct as at the Closing Date;

(b)              
OCLG shall have performed all its obligations under this Agreement to be performed by it on or prior to the Closing Date
and OCLG shall not be in breach of any agreement on its part contained in this Agreement;

 

B-17

 

    	 

    	 

    

(c)               
all documents relating to the due authorization and completion of the transactions contemplated hereby and all actions
and proceedings taken on or prior to the Closing Date in connection with the performance by OCLG of its obligations under this
Agreement shall be satisfactory to Seller and their counsel and Seller shall have received copies of all such documents or other
evidence as they may reasonably request in form and substance satisfactory to Seller and their counsel;

 

If any of the conditions contained
in Section 8.2 hereof shall not be fulfilled or performed on or before the Closing Date to the reasonable satisfaction of Seller,
Seller may, by written notice to OCLG, terminate all their obligations hereunder.

8.3             
Conditions to the Seller and DRC’s Obligations. At closing, Seller shall receive from OCLG a certificate to
the effect that:

(a)               
the accuracy in all material respects (except for those representations and warranties that are qualified by materiality
or a material adverse effect qualifier, which shall be true and correct in all respects) when made and on the Closing Date (except
for representations and warranties that speak as of a specific date, which shall be true and correct as of such specified date)
of the representations and warranties of each OCLG contained herein;

(b)               
all obligations, covenants and agreements of OCLG required to be performed at or prior to the Closing Date shall have been
performed;

(c)               
no action, proceeding, investigation, regulation or legislation shall have been instituted, threatened or proposed before
any court, governmental agency or authority or legislative body to enjoin, restrain, prohibit, or obtain substantial damages in
respect of, this Agreement or the consummation of the transactions contemplated by this Agreement;

(d)            within 75 days
of the closing date, OCLG shall have transferred ownership of its subsidiary Oncologix Corporation in partial settlement of an
outstanding debtednesss of Oncologix Tech, Inc. in accordance with the requirements of the Nevada Law.

8.4             
Conditions to OCLG’s Obligations. At Closing, OCLG shall receive a certificate of the Seller and DRC to the
effect that:

(a)               
the accuracy in all material respects (except for those representations and warranties that are qualified by materiality
or a material adverse effect qualifier, which shall be true and correct in all respects) when made and on the Closing Date (except
for representations and warranties that speak as of a specific date, which shall be true and correct as of such specified date)
of the representations and warranties of the Seller and DRC contained herein;

(b)              
all obligations, covenants and agreements of the Seller and DRC required to be performed at or prior to the Closing Date
shall have been performed;

B-18

 

    	 

    	 

    

 

(c)               
the Seller and DRC shall obtain with the cooperation of OCLG any and all Required Consents as hereinafter defined, if any,
and shall have provided OCLG with true and correct copies thereof;

(d)              
no action, proceeding, investigation, regulation or legislation shall have been instituted, threatened or proposed before
any court, governmental agency or authority or legislative body to enjoin, restrain, prohibit, or obtain substantial damages in
respect of, this Agreement or the consummation of the transactions contemplated by this Agreement;

(e)               
nothing shall have occurred or been discovered prior to the Closing Date that would reasonably be expected, either individually
or collectively, to have a materially adverse effect on the business, operations, financial condition, prospects or assets of the
Seller and DRC or their Affiliates Subsidiaries (a “Material Adverse Effect”);

 

9.                 
Deliveries at Closing:

 

9.1             
Deliveries by OCLG: At the Closing, or as described below, OCLG shall deliver to Seller and DRC:

(a)               
Certificates for the New Preferred Shares as soon as possible after the Closing but no later than 30 days after the Closing;

(b)              
Minutes of its Board of Directors approving the execution and delivery of this Agreement and each of the documents and instruments
contemplated hereby and the election of R. Wayne Erwin as Director and CEO together with the resignation of one of its’ present
directors and all of its CEO;

 

(c)          A
certificate of compliance with representations warranties and covenants executed by its CEO;

		(a)	The Employment Agreement; and

		(b)	Such other documents and instruments as Seller or its counsel may reasonably request.

 

		9.2	Deliveries by Seller and DRC: At the Closing Seller and DRC shall deliver to OCLG:

 

(a)         Certificates for the DRC Shares;

 

(b)
      Minutes of their governing bodies approving the execution and delivery of this Agreement and
each of the documents and instruments contemplated hereby;

 

B-19

 

    	 

    	 

    

 

(c)               A certificate of compliance
with representations warranties and covenants executed by their CEO or managing member;

 

(d )               Evidence of the investment
by a third party for the benefit of DRC of no less than $50,000;

 

(e )                An undertaking by counsel
to issue a 10b-5 opinion to the Board of directors of OCLG with respect to the Form 8-K and any amendment thereto that discloses
this Agreement and the transactions contemplated thereby; and

 

(f)               Such other documents and instruments as Seller or its counsel may reasonably request.

10.          Termination

This Agreement may
not be terminated at any time prior to the Closing Date referred to in Section 3 hereof by OCLG, Seller or DRC except by their
mutual consent or except in the case on a substantial and non-curable breach by the non-terminating party.

11.          Indemnification

11.1Each party
hereto agrees to indemnify and hold harmless the other party from and in respect of any cost, claim, loss, damage, liability or
expense which such other party may suffer or incur, whether at law or in equity, arising out, resulting from or in connection with
the inaccuracy of any representation or warranty contained herein, for the time periods provided in Section 5.1 hereof.

11.2               No claim for
indemnification will arise until written notice thereof is given to the party from whom indemnification is sought or claimed (the
“Indemnitor”). Such notice shall be sent within a reasonable time following the determination by the party seeking
indemnification (the "Indemnitee") that a claim for indemnity may exist. In the event that any legal proceedings
shall be instituted or any claim or demand is asserted by any third person in respect of which either party may seek any indemnification
from the other party, the Indemnitee shall give or cause to be given to the Indemnitor written notice thereof and the Indemnitor
shall have the right, at its option and expense, to be present at the defense of such proceedings, claim or demand, but not to
control the defense, negotiation or settlement thereof, which control shall at all times remain with the Indemnitee, unless the
Indemnitor irrevocably acknowledges full and complete responsibility for indemnification of the Indemnitee in respect of the subject
claim, in which case the Indemnitor may assume such control through counsel of its choice; provided, however, that
no settlement shall be entered into without the Indemnitee's prior written consent (which shall not be unreasonably withheld).
The parties agree to cooperate fully with each other in connection with the defense, negotiation or settlement of any such third
party legal proceeding, claim or demand.

B-20

 

    	 

    	 

    

 

11.3               Notwithstanding
anything in this Agreement to the contrary, the indemnity provided for in this Section 11 shall apply to any loss, claim, cost,
damage, expense or liability, whether or not the actual amount thereof shall have been ascertained prior to the final day upon
which a claim for indemnity with respect thereto may be made hereunder in accordance with Section 5 hereof, so long as written
notice thereof shall have been given to the party from whom indemnification is sought prior to said date, setting forth specifically
and in reasonable detail, so far as is known, the matter as to which indemnification is being sought, but nothing herein shall
be construed to require payment of any claim for indemnity until the actual amount payable shall have been finally ascertained. 

12.               Notices

Notices required
or permitted to be given under this Agreement shall be in writing and shall be deemed to be sufficiently given when sent by certified
or registered mail or by overnight courier or by hand, addressed to the addresses set forth on the first page of this Agreement
or to such other address furnished by notice given in accordance with this Section 11.

13.               Governing Law

This Agreement shall
be governed by and construed in accordance with the laws of the State of Arizona. In the event there is any dispute between the
parties as to their rights and obligations under this Agreement, the parties submit to the jurisdiction of any state or federal
court sitting in Maricopa County, Arizona and waive any defense of inconvenient forum to the maintenance of any action so brought.

14.               Entire
Agreement

This Agreement constitutes
the entire agreement between the parties relating to the subject matter hereof. There are no verbal statements, representations,
warranties, undertakings or agreements between the parties. This agreement may be amended only by an instrument in writing signed
by both parties.

15.               Time
of the Essence

Time shall be of the
essence of this Agreement.

16.               Assignment

Neither this Agreement
nor any rights or obligations hereunder may be assigned by either party without the prior written consent of the other party, which
consent may be withheld in either party's sole and absolute discretion, except that OCLG may assign its rights hereunder to an
entity that is substantially owned by OCLG without Seller’ consent.

17.               Binding
Effect

This Agreement shall
be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Agreement
may be executed in counterparts.

B-21

 

    	 

    	 

    

 

IN WITNESS WHEREOF,
the parties have executed this Agreement as of the date first above written.

	 	Oncologix, Tech Inc.
	 	 
	 	By:
	 	Barry Griffith, CEO
	 	 
	 	 
	 	Clearview Medical, LLC
	 	 
	 	By:
	 	R. Wayne Erwin
	 	Chief Executive Officer
	 	 
	 	 
	 	Dototo Research Corporation
	 	 
	 	By:
	 	R. Wayne Erwin, 
	 	Chief Executive Officer
	 	 
	 	 

B-22Exhibit
10.2

EXECUTIVE
EMPLOYMENT AGREEMENT

This
EXECUTIVE EMPLOYMENT AGREEMENT ("Agreement") is made and entered into as of March 15, 2013, by and between Oncologix,
Tech, (Company), a company duly incorporated and validly existing under the laws of Nevada and Roy Wayne Erwin ("Executive"),
with principal office located at 212 Edgewood Drive, Pineville, Louisiana, 71360.

RECITALS

A.
WHEREAS, contemporaneously with this Agreement, Oncologix, Inc. has entered into an agreement with Clearview Medical, LLC
pursuant to the terms of a Stock Purchase Agreement (“SPA”) dated effective the same date as this Agreement
to acquire 1,000 shares of Common Stock of Dotolo Research Corporation from Clearview medical, LLC;

B.
WHEREAS, the Company wishes to ensure that it will have the benefits and knowledge of Employee's services and expertise
on the terms and conditions hereinafter set forth; and

C.
WHEREAS, Dotolo Research Corporation is engaged in the business of the manufacture and distribution of medical device products
and services used in gastrointestinal, OB/GYN, skilled nursing facilities, and health and wellness spas with distribution both
U.S. and international.

D.
WHEREAS, the Company desires to engage the Executive as its Chairman and Chief Executive Officer and on the Board of Directors
and the Executive desires to provide employment services to the Company on all of the terms and conditions herein set forth.

E.
WHEREAS, the Company desires to provide the Executive with compensation in recognition of the Executive's valuable skills
and services.

NOW,
THEREFORE, in consideration of the mutual covenants and conditions herein contained, the parties hereto agree as follows:

ARTICLE
I. DEFINITION

In
this Agreement, unless the context otherwise requires, the following words shall have the following meaning:

"Board"
means the Board of Directors of the Company;

"Company"
means Oncologix, a company duly incorporated and validly existing under the laws of the Nevada;

"Commencement
Date" means February 22, 2013, the date of commencement of Employment;

"Company
Group" means the Company and all of its subsidiaries;

"Employment"
means the employment of the Executive under the terms herein;

"Executive"
means Roy Wayne Erwin, a citizen of the United States of America ;

Confidentiality
and Non-Competition Agreement" means the Confidentiality and Non-competition Agreement to be executed by and between the
Company and Executive;

1

 

    	 

    	 

    

 

ARTICLE
II. POSITION AND DUTIES

2.1 Employment.
The Company hereby employs the Executive as its Chairman and Chief Executive Officer and the Executive hereby accepts such engagement
with the Company, in accordance with and subject to all of the terms, conditions and covenants set forth in this Agreement. The
Executive principal office is located at 212 Edgewood Drive, Pineville, Louisiana 71360 and Dotolo Research Corporation manufacturing
facilities located at 3731 East Lasalle Street, Phoenix, Arizona, 85040, and the Executive will travel as required both within
the US and internationally.

2.2 Scope
of Duties. The Executive shall be the Chairman and Chief Executive Officer and shall have such other or additional offices
or positions with the Company as the Board of Directors (the "Board") shall determine from time to time. The Executive
shall have responsibility for the following duties, operating within such established guidelines, plans or policies as may be
established or approved by the Board from time to time:

(a)
development of Company business plans, strategic plans, financial plans, directly responsible for the financial viability of the
Company, assisting and supervising the financial and accounting matters of the Company and its subsidiaries, including organizing,
managing and supervising the work of the President, Chief Financial Officer, Sales and Marketing Director, and oversight of the
manufacturing/operations of the Company;

(b)
assist the Chief Financial Officer in preparing the financial statements of the Company and its subsidiaries in accordance with
accounting principles generally accepted in the United States ("USGAAP"), or such other accounting principles as the
Board may direct, and recommending appropriate accounting treatment in accordance with USGAAP or such other principles;

(c)
assist and cooperate with the Company's independent accountants in their audit and review of the Company's financial statements;

(d)
participate in new product development, to improve, document, test and certify Company products, implement the Company's internal
controls over financial reporting; assisting and cooperating with any consulting firm engaged by the Company in connection with
such projects; oversight and supervising the CFO with implementation of internal controls over financial reporting in the Company's
finance and accounting department; and assisting and cooperating with the Company's internal audit in the implementation and review
of such controls;

(e)
supporting the Company Board of Directors, company legal representative, and the Chief Financial Officer in such matters as preparation
and presentation of such financial and statistical reports as may be requested from time to time and assisting in the Company's
business and strategic planning and preparation of annual budgets;

 

2

 

 

    	 

    	 

    

(f)
participating in the preparation and filing of annual and quarterly reports (8k-10Q) and providing such certifications as may
be required by the Security Exchange Commission (SEC) in connection therewith;

(g)
participating in investor communications, including analyst conference calls, road shows and others; and

(h)
such other responsibilities and duties customarily performed by the Chief Executive Officer of companies in the same industry
and listed companies.

2.3 Other
Business Affiliations. The Executive agrees that, without the approval of the Board, the Executive shall not, during the period
of employment with the Company, devote more than 15% at any time to any other business affiliation which would interfere with
or derogate from Executive's obligations under this Agreement. The Executive represents and warrants that his service as such
Executive does not create any conflict of interest in relation to his duties and obligations to the Company hereunder, and agrees
that in the event such a conflict arises, he will promptly report it to the Board.

2.4 No
Breach of Duty. The Executive represents that the Executive's performance of this Agreement and as an employee of the Company
does not and will not breach any agreement or duty to keep in confidence proprietary information acquired by the Executive in
confidence or in trust (i) prior to employment with the Company or (ii) pursuant to his service referred to in Section 2.3.
The Executive has not and will not enter into any agreement either written or oral in conflict with this Agreement. The Executive
is not presently restricted from being employed by the Company or entering into this Agreement.

 

3

 

    	 

    	 

    

  

ARTICLE
III. DURATION

3.1 Commencement
Date. The Executive's first day of employment shall be February 22, 2013 ("Commencement Date").

3.2 Term.
This Agreement shall continue for an initial term of three (3) years from the Commencement Date unless otherwise terminated
in accordance with Article 8 below. Upon the expiration of the initial term, this Agreement shall be automatically extended for
successive periods of twelve (12) months, unless terminated by either party upon ninety (90) days' notice prior to the
expiration of the initial term or any subsequent terms.

ARTICLE
IV. COMPENSATION

4.1 Salary.
The Executive shall be paid an initial base annual salary of $120,000 per annum, less deductions required by law, which shall
be paid in equal monthly installments in the U.S. dollar equivalent with the Company's normal and customary payroll practices.
Such salary shall be increased at a minimum of 5% per year, reviewed annually, and any base salary increases or decreases will
be approved by the Board of Director, Compensation Committee. If inadequate funds are available, the salary and other benefits
and expenses not paid to Executive, shall be accrued per quarter. At the end of the quarter, at the Executives option, the accrued
salary may be converted into Company stock at a price equivalent to the lowest five (5) day average bid price during the preceding
quarter.

4.2
PROFESSIONAL FEES. The Company shall have exclusive authority to determine the fees, or a procedure for establishing
the fees, to be charged by the Company. All sums paid to the Executive or the Company in the way of fees or otherwise for other
services of the Executive, shall, except as otherwise specifically agreed by the Company, be and remain the property of the Company
and shall be included in the Company's name in such checking account or accounts as the Company may from time to time designate.

4.3
CLIENTS AND CLIENT RECORDS.  The Company shall have the authority to determine who will be accepted as clients
of the Company, and the Executive recognizes that such clients accepted are clients of the Company and not the Executive. The
Company shall have the authority to designate, or to establish a procedure for designating which professional Executive of the
Company will handle each such client. All client records and files of any type concerning clients of the Company shall belong
to and remain the property of the Company, notwithstanding the subsequent termination of this Agreement.

4.4
POLICIES AND PROCEDURES. The Company shall have the authority to establish from time to time the policies and
procedures to be followed by the Executive in performing services for the Company. Executive shall abide by the provisions of
any contract entered into by the Company under which the Executive provides services. Executive shall comply with the terms and
conditions of any and all contracts entered by the Company.

4.5 Bonus.
The Executive shall be eligible for an annual performance-based cash bonus at the discretion of the Board.

4.6 Reimbursable
Expenses. The Company shall reimburse the Executive for all reasonable business expenses incurred in the performance of the
Executive's duties hereunder on behalf of the Company, subject to submission of expense reports and approval according to the
Company's financial regulations.

4.7 Automobile.
During his employment, the Executive will be provided a Not to Exceed, flat rate of $ 650.00 per month as an automobile allowance
by the Company payable within ten (10) days after the 1st of every month.

4.8 Income
Taxes. The payment of tax, social security and similar payments arising out of this Agreement shall be dealt with by the parties
in accordance with applicable laws and regulations.

4

 

    	 

    	 

    

 

The
Executive agrees to any withholdings that must be made by the Company pursuant to such laws and regulations. Furthermore, the
Executive undertakes to promptly discharge any payments that are payable by him pursuant to such laws and regulations and agrees
to indemnity the Company and hold the Company harmless from any and all claims made by any entity on account of an alleged failure
by the Executive to satisfy such obligations.

ARTICLE
V. OTHER BENEFITS, VACATION , HOLIDAYS, INSURANCE

5.1 Vacation.
The Executive shall be entitled in each calendar year to twenty (20) working days' vacation with full salary (in addition
to statutory holidays) to be taken at such reasonable time or times as approved by the Board. The Executive may accumulate and
carry forward unused vacation to the following calendar year. The entitlement to vacation and, on termination of employment, vacation
pay in lieu of vacation, shall accrue pro rata throughout each calendar year of the period of employment.

5.2 Holidays.
The Executive shall be entitled to the all statutory public holidays observed.

5.3
Benefits. Employee shall be entitled to participate in any and all medical insurance, group health care programs (including
dental, vision and prescription drug programs), disability insurance, pension and other benefit plans which are made generally
available by the Company to other similarly situated senior level employees performing similar functions as Executive. The Company,
in its sole discretion, may at any time amend or terminate its benefit plans or programs; provided, however, that the Company
shall not do so except to the extent that such amendment or termination is in good faith and applies generally to all employees
of the Company.

If
the Company does not have an Executive Benefit program available, the company will provide a monthly fixed amount of $600.00 to
secure Health/Dental and Long Term Disability insurance.

5.4
Key Man Insurance. The Company may maintain, at its expense, Key Man Life Insurance (the "Policy") on
the life of Employee for the benefit of the Company with a benefit of One Million Dollars ($1,000,000). Employee's signature to
this Agreement constitutes Employee's written consent to being insured under the Policy and that the Company may continue such
life insurance coverage after Employee's employment with the Company terminates, regardless of the cause of such termination.
Employee shall make all necessary applications, submit to physical examinations and otherwise cooperate with the Company with
respect to the purchase of the policy.

5.5
Death of Executive. In the event the Executive shall die during the term hereof, the Company shall pay to the Executive's
surviving spouse, or if the Executive shall leave no surviving spouse, then to the Executive's estate, only such amounts as may
have been earned by the Executive prior to the Executive's date of death, but which were unpaid at date of death.

5.6
Life Insurance. Company shall provide a term life policy to Executive in the face value amount of 3x annual base salary.

5

 

    	 

    	 

    

 

ARTICLE
VI. CONFIDENTIALITY, NONSOLICITATION AND NONCOMPETITION

6.1 Confidentiality.
During his employment, the Executive will have access to, will become acquainted with various trade secrets, confidential and
proprietary information relating to the business of the Company and its subsidiaries, including but not limited to customer, employee,
supplier, and distributor lists, contacts, addresses, information about employees and employee relations, training manuals and
procedures, recruitment methods and procedures, business plans and projections, employment contracts, employee handbooks, information
about customers and suppliers, price lists, costs and expenses, documents, budgets, proposals, financial information, inventions,
patterns, processes, formulas, data bases, know how, developments, experiments, improvements, computer programs, manufacturing,
recruitment and distribution techniques, specifications, tapes, and compilations of information, all of which are owned by the
Company and its subsidiaries, other parties with which the Company and its subsidiaries do business ("Third Parties")
or customers of the Company and its subsidiaries, and which are used in the operation of the business of the Company and its subsidiaries,
or such Third Parties or customers. The Executive agrees at all times during the term of his employment and thereafter to hold
in strictest confidence, and not to use, except for the benefit of the Company, or to disclose directly or indirectly to any person,
firm or corporation without written authorization of the Board, any trade secrets or confidential information. In addition, the
Executive understands "trade secret" or "confidential information" means all information concerning the Company
and its subsidiaries, Third Parties and/or customers (including but not limited to information regarding the particularities,
preferences and manner of doing business) that is (i) not generally known to the public and (ii) cannot be discovered
or replicated by a third party without substantial expense and effort.

6.2 Non-Solicitation.
The Executive agrees that during the Executive's employment and for a period of the later of two (2) years after the termination
of employment hereunder where the Company does business, the Executive shall not:

(i)
directly call upon or solicit any of the customers of the Company or its subsidiaries that were or became customers during the
term of the Executive's employment (as used herein "Customer" shall mean any person or company as listed as such on
the books of Company or its subsidiaries); or

(ii)
induce or its subsidiaries attempt to induce any employee, agent or consultant of the Company or its subsidiaries to terminate
his or her association with the Company or its subsidiaries.

6.3 Non-Competition.
The Executive agrees that during the Executive's employment and for a period of two (2) years , subject to Section 2.3,
devote full time to the business of the Company and will not directly or indirectly, engage, individually or as an officer, director,
employee, consultant, advisor, partner or co-venture, or as a stockholder or other proprietor owning an interest in any firm,
corporation, partnership or other organization in the business of manufacturing, selling or distributing products in competition
with the products and/or services of the Company and its subsidiaries. The Executive shall, during the term of the Executive's
employment and the term of the non-competition restriction, furnish to the Board a detailed statement of any outside employment
or consulting services in which the Executive seeks to engage or invest, and, as from time to time requested by the Board, resubmit
for approval a detailed statement thereof. In the event the Board determines in good faith that such violation or conflict exists,
the Executive shall refrain from such employment, consulting services or investment.

6.4 Enforceability.
The Executive agrees that, having regard to all the circumstances, the restrictions in this Article 6 are reasonable and necessary
but no more than sufficient for the protection of the Company. The Company and Executive agree that:

(i)
each restriction in this Article 6 shall be read and construed independently of the other restrictions so that if one or more
are found to be void or unenforceable as an unreasonable restraint of trade or for any other reason, the remaining restrictions
shall not be affected; and

(ii)
if any restriction is found to be void but would be valid and enforceable if some part of it were deleted or the period thereof
were deleted or the range of activities or area dealt with thereby were reduced in scope, the restriction shall apply with such
modifications as may be necessary to make it valid and enforceable.

6.5 Injunctive
Relief. In the event of the breach or threatened breach by the Executive of this Article 6, the Company, in addition to all
other remedies available to it at law or in equity, will be entitled to seek injunctive relief and/or specific performance to
enforce this Article 6 in any court of competent jusridiction. 

6.6
Assignment and Transfer. Executive’s rights and obligations under this Agreement shall not be transferable by assignment
or otherwise, and any purported assignment, transfer or delegation thereof shall be void. This Agreement shall inure to the benefit
of, and be binding upon and enforceable by, any purchaser of substantially all of Company’s assets, any corporate successor
to Company or any assignee thereof.

 

6

 

    	 

    	 

    

 

ARTICLE
VII. ASSIGNMENT OF INVENTIONS AND INTELLECTUAL PROPERTY

7.1
The parties foresee that the Executive has created and may create designs or other intellectual property in the course of his
duties hereunder and agree that in this respect the Executive has a special responsibility to further the interests of the Company.

7.2
Any invention, production, improvement or design made or process or information discovered or copyright work or trade mark or
trade name or get-up source code or any other intellectual property created by the Executive during the continuance of his Employment
hereunder (whether before or after the date hereof or whether capable of being patented or registered or not and whether or not
made or discovered in the course of his employment hereunder) in conjunction with or in any way affecting or relating to the business
of any company in the Company or capable of being used or adapted for use therein or in connection therewith shall forthwith be
disclosed to the Company and shall belong to and be the absolute property of such company in the Company Group as the Company
may direct.

7.3
The Executive if and whenever required to do by the Company shall at the expense of the Company apply or join in applying for
letters patent or other protection or registration for any such invention, improvement design process information work trade mark
name or get-up source code or other intellectual property rights as aforesaid which belongs to such company and shall at the expense
of such company execute and do all instruments and things necessary for vesting the said letters patent or other protection or
registration when obtained and all right title and interest to and in the same in such company absolutely and as sole beneficial
owner or in such other person as the Company may specify.

7.4
The Executive hereby irrevocably appoints the Company to be his attorney in his name and on his behalf to execute and do any such
instrument or thing and generally to use his name for the purpose of giving to the Company the full benefit of this Article and
in favor of any third party a certificate in writing signed by any Executive or by the secretary of the Company that any instrument
or act falls within the authority hereby conferred shall be conclusive evidence that such is the case.

 7

 

 

    	 

    	 

    

ARTICLE
VIII. TERMINATION

8.1
Except as otherwise provided in Sections 3.3 and 8.2, the Executive employment may be terminated by either party giving the other
not less than ninety (90) days' notice in writing provided that the Company shall have the option to pay salary (pro-rated)
in lieu of any required period of notice. Notwithstanding the ninety (90) days' notice requirement in this Section 8.1,
the Executive agrees to continue to perform his duties hereunder until a new Chief Executive Officer of the Company is appointed
and ensure a smooth transition thereafter, and the terms of this Agreement shall continue to apply; provided that any such extension
shall not exceed ninety (90) days. During such ninety (90) days' notice period and any extension thereof pursuant to
this Section 8.1, the Company shall use its diligent efforts to recruit a new Chief Executive Officer.

8.2
Notwithstanding the other provisions of this Agreement, the Company may terminate the Employment with cause forthwith without
prior notice (but without prejudice to the rights and remedies of the Company) for any breach of this Agreement in any of the
following cases:

(i)
if the Executive fails or neglects efficiently and diligently to carry out his duties to the reasonable satisfaction of the Board; 

(ii)
if the Executive is guilty of serious misconduct in connection with the Employment;

(iii)
if the Executive is convicted of any criminal offense, which might reasonably be thought to adversely affect the performance of
his duties;

(iii
if the Executive does any act or thing which may bring serious discredit on the Company or the Company Group;

(iv)
if the Executive commits any serious breach of the Company's By-Laws and operating procedures (as laid down by the Company and
communicated to the Executive from time to time) and has caused serious financial loss to the Company;

(v)
if the Executive fails to observe and perform any of the duties and responsibilities imposed by this Agreement or which are imposed
by law, or is in breach of any representation, warranty or covenant made by the Executive under this Agreement;

(vi)
if the Executive becomes unsound of mind or suffers from a mental disorder; or

(vii)
if the Executive otherwise acts in breach of this Agreement so as materially to prejudice the business of the Company or the Company
Group.

8.3
The Executive shall not, at any time after termination of the Employment for whatever reason, represent himself as being in any
way connected with the business of the Company.

8.4
Upon termination of the Employment for whatever reason, the Executive shall forthwith deliver to the Company or its authorized
representative such of the following as are in his possession or control:

(i)
All keys, security and computer passes, plans statistics, documents, records, papers, magnetic disks, tapes or other software
storage media including all copies, records and memoranda (whether or not recorded in writing or on computer disk or tape) made
by the Executive of any confidential or proprietary information relating to the business of the Company and its subsidiaries;

(ii)
All credit cards and charge cards provided for the Executive's use by the Company; and

(iii)
All other property of the Company not previously referred to in this Article; and

8

 

 

    	 

    	 

    

 

(iv)
any breach of this Agreement, which breach is not cured within thirty (30) days following written notice of such breach; and

8.5
Termination With-Out Cause. The Company may terminate Executive’s employment hereunder at any time without cause,
provided, however, that Executive shall be entitled to severance pay in the amount of 26 weeks of Base Salary in addition to accrued
but unpaid Salary and accrued vacation, less deductions required by law, but only if, Executive executes a valid and comprehensive
release of any and all claims that the Executive may have against the Company in a form provided by the Company and Executive
executes such form within ten (10) days of tender.

8.6
Resignation. Upon termination by reason of “For Cause “of employment, Executive shall be deemed to have resigned from
the Board of Directors of the Company.

8.7
DISABILITY OF EXECUTIVE

The
Company may terminate this Agreement without liability if Executive shall be permanently prevented from properly performing his
essential duties hereunder with reasonable accommodation by reason of illness or other physical or mental incapacity for a period
of more than 180 consecutive days. Upon such termination, Executive shall be entitled to all accrued but unpaid Base Salary and
vacation.

(i)
Definitions - For purposes of this Agreement, whenever used in this Section 8.3:

"Total
disability" shall mean that the Executive is unable, mentally or physically, whether it be due to sickness, accident, age
or other infirmity, to engage in any aspect of the Executive's normal duties as set forth in this Agreement.

9

 

 

    	 

    	 

    

"Partial
disability" shall mean that the Executive is able to perform, to some extent, on behalf of the Company, the particular services
in which the Company specializes, and which the Executive previously performed for the Company, but that the Executive is unable,
mentally or physically, to devote the same amount of time to such services as was devoted prior to the occurrence of such sickness
or accident.

"Normal
monthly salary" shall mean the salary which the Executive is being paid by the Company per month as of the commencement date
of the period of disability, as specified hereinabove or as determined by the Board of Directors pursuant to the terms hereof.

(ii)
Total Disability

During
a single period of total disability of the Executive, the Executive shall be entitled to receive from the Company, the Executive's
normal monthly salary for the shorter of first three (3) months of disability or until any disability insurance policy available
through the Executive’s employment begins to pay benefits. If the single period of disability should continue beyond three
(3) months, the Executive shall receive only such amount as the Executive shall be entitled to receive under disability insurance
coverage on the Executive, if any.

(iii)
Partial Disability

During
a period of partial disability of the Executive, the Executive shall receive an amount of compensation computed as follows:

That
portion of the Executive's normal monthly basic compensation which bears the same ratio to the Executive's normal monthly basic
compensation as the amount of time which the Executive is able to devote to the usual performance of services on behalf of the
Company during such period bears to the total time the Executive devoted to performing such services prior to the commencement
date of the single period of disability, and such amount shall be calculated by multiplying the Executive’s basic compensation
by a fraction, the numerator of which shall be the percentage of normal services that the Executive is able to perform and the
denominator which shall be the total services that the Executive is able to perform absent the partial disability.

(iv)
Combination of Total and Partial Disability

If
a single period of disability of the Executive consists of a combination of total disability and partial disability, the maximum
total disability compensation to which the Executive shall be entitled from the Company under this disability provision shall
not exceed an amount equal to one (1) times the Executive's normal monthly basic compensation.

(V)
Broken Periods of Disability

A
period of disability may be continuous or broken. If broken into partial periods of disability which are separated by intervening
periods of work, there shall be aggregated together all of such successive partial periods of disability except any period prior
to the time when any single period of work extends for three months or longer; and such aggregated periods of disability shall
be treated as a single period in determining the amount of disability compensation to which an Executive shall be entitled under
any provision of this Section.

10

 

 

    	 

    	 

    

8.6
Termination Due to Disability

If
and when the period of total or partial disability of the Executive totals [NUMBER] months, the Executive's employment with the
Company shall automatically terminate. Notwithstanding the foregoing, if the disabled Executive and the Company agree, the disabled
Executive may thereafter be employed by the Company upon such terms as may be mutually agreeable.

8.7
Commencement Date of Disability

The
commencement date of a period of disability, whether it be a continuous period or the aggregate of successive partial periods,
shall be the first day on which the Executive is disabled.

8.8
Dispute Regarding Existence of Disability

Any
dispute regarding the existence, extent or continuance of the disability shall be resolved by the determination of a majority
of three (3) competent physicians, one (1) of whom shall be selected by the Company, one (1) of whom shall be selected by the
Executive and the third (3rd) of whom shall be selected by the other two (2) physicians so selected.

ARTICLE
IX- INDEMNIFICATION

9.1
The Executive hereby agrees to indemnify and hold the Company and its officers, directors, shareholders and Executives harmless
from and against any loss, claim, damage or expense, and/or all costs of prosecution or defense of their rights hereunder, whether
in judicial proceedings, including appellate proceedings, or whether out of court, including without limiting the generality of
the foregoing, attorneys' fees, and all costs and expenses of litigation, arising from or growing out of the Executive's breach
or threatened breach of any covenant contained herein.

9.2
The Company hereby agrees to indemnify and hold the Executive harmless from and against any loss, claim, damage or expense, and/or
all costs of prosecution or defense of their rights hereunder, whether in judicial proceedings, including appellate proceedings,
or whether out of court, including without limiting the generality of the foregoing, attorneys' fees, and all costs and expenses
of litigation, arising from or growing out of the Company’s breach or threatened breach of any covenant contained herein.

ARTICLE
X. MISCELLANEOUS PROVISIONS/JURISDICTION

10.1 Severability.
I If any term or provision of this Agreement shall be held to be invalid or unenforceable
for any reason, such term or provision shall be ineffective to the extent of such invalidity or unenforceability without invalidating
the remaining terms and provisions hereof, and this Agreement shall be construed as if such invalid or unenforceable term or provision
had not been contained herein.

11

 

    	 

    	 

    

 

10.2
Rights Cumulative. The rights and remedies provided by this Agreement are cumulative, and the exercise of any right
or remedy by either party hereto (or by its successor), whether pursuant to this Agreement, to any other agreement, or to law,
shall not preclude or waive its right to exercise any or all other rights and remedies.

10.3
Nonwaiver. No failure or neglect of either party hereto in any instance to exercise any right, power or privilege
hereunder or under law shall constitute a waiver of any other right, power or privilege or of the same right, power or privilege
in any other instance. All waivers by either party hereto must be contained in a written instrument signed by the party to be
charged and, in the case of the Company, by an officer of the Company (other than Executive) or other person duly authorized by
the Company.

10.4
Assistance in Litigation. Executive shall, during and after termination of employment, upon reasonable notice, furnish
such information and proper assistance to the Company as may reasonably be required by the Company in connection with any litigation
in which it or any of its subsidiaries or affiliates is, or may become a party; provided, however, that such assistance following
termination shall be furnished at mutually agreeable times and for mutually agreeable compensation.

10.5 Survival.
Articles 6 and 7 and Section 9.7 shall survive the termination of this Agreement.

10.6 Entire
Agreement. This Agreement, together with all award agreements and long-term incentive agreements is the entire agreement between
the parties hereto concerning the subject matter hereof and supersedes and replaces all prior or contemporaneous agreements or
understandings between the parties.

10.7 Employment
Amendments. This Agreement may not be amended or modified in any manner, except by an instrument in writing signed by duly
authorized members of the Board.

10.8 Notices.
Unless otherwise provided herein, any notice required or permitted under this Agreement shall be given in writing and shall
be deemed to have been duly given upon personal delivery to the party to be notified or five (5) business days after being mailed
by United States certified or registered mail, postage prepaid, return receipt requested or two (2) days after being sent by Federal
Express or other recognized overnight delivery to the following respective addresses, or at such other address as each may specify
by notice to the other:

 

 

 

Notice
to the Executive: 

Roy
Wayne Erwin

Chairman-Chief
Executive Officer

212
Edgewood Drive

Pineville,
Louisiana 71360

12

 

    	 

    	 

    

 

10.9 Governing
Law. This Agreement shall be governed by and construed in all respects in accordance with the laws of the State of Louisiana.

11.1 Jurisdiction.
Unless otherwise provided for in this Agreement, the courts within the Parish of Rapides, and the City of Alexandria, Louisiana
shall have exclusive jurisdiction to adjudicate any dispute arising out of this Agreement and/or employment relationship or termination
thereof and the Executive consents to such jurisdiction and venue. 

11.2
Construction. The headings and captions of this Agreement are provided for convenience only and are intended to
have no effect in construing or interpreting this Agreement. The language in all parts of this Agreement shall be in all cases
construed according to its fair meaning and not strictly for or against the Company or Executive.

11.3
Nonwaiver. No failure or neglect of either party hereto in any instance to exercise any right, power or privilege
hereunder or under law shall constitute a waiver of any other right, power or privilege or of the same right, power or privilege
in any other instance. All waivers by either party hereto must be contained in a written instrument signed by the party to be
charged and, in the case of the Company, by an officer of the Company (other than Executive) or other person duly authorized by
the Company.

11.4
Arbitration. Any controversy, claim or dispute arising out of or relating to this Agreement or the employment relationship,
either during the existence of the employment relationship or afterwards, between the parties hereto, their assignees, their affiliates,
their attorneys, or agents, shall be settled by arbitration in Alexandria, Louisiana. Such arbitration shall be conducted in accordance
with the then prevailing commercial arbitration rules of the State of Louisiana but the arbitration shall be in front of an arbitrator,
with the following exceptions if in conflict: (a) one arbitrator shall be chosen by Roy Wayne Erwin; (b) each party
to the arbitration will pay its pro rata share of the expenses and fees of the arbitrator(s), together with other expenses of
the arbitration incurred or approved by the arbitrator(s); and (c) arbitration may proceed in the absence of any party if
written notice of the proceedings has been given to such party. The parties agree to abide by all decisions and awards rendered
in such proceedings. Such decisions and awards rendered by the arbitrator shall be final and conclusive and may be entered in
any court having jurisdiction thereof as a basis of judgment and of the issuance of execution for its collection. All such controversies,
claims or disputes shall be settled in this manner in lieu of any action at law or equity; provided however, that nothing in this
subsection shall be construed as precluding the Company from bringing an action for injunctive relief or other equitable relief
or relief under the Confidential Information and Invention Assignment Agreement. The arbitrator shall not have the right to award
punitive damages, consequential damages, lost profits or speculative damages to either party. The parties shall keep confidential
the existence of the claim, controversy or disputes from third parties (other than the arbitrator), and the determination thereof,
unless otherwise required by law or necessary for the business of the Company. The arbitrator(s) shall be required to follow applicable
law.

13

 

    	 

    	 

    

  

IF
FOR ANY REASON THIS ARBITRATION CLAUSE BECOMES NOT APPLICABLE, THEN EACH PARTY, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AS TO ANY ISSUE RELATING HERETO IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER MATTER INVOLVING THE PARTIES HERETO.

 

12.0
Acknowledgment. The Executive acknowledges that when this Agreement is concluded, the Executive will be able to earn a
living without violating the foregoing restrictions and that the Executive's recognition and representation of this fact is a
material inducement to the execution of this Agreement and to Executive's continued relationship with the Company.

12.1
Survival of Covenants . All restrictive covenants contained in this Agreement shall survive the termination of this Agreement.

12.2
Limitations on Authority . Without the express written consent from the Company, the Executive shall have no apparent or
implied authority to: (i) Pledge the credit of the Company or any of its other Executives; (ii) Bind the Company under any contract,
agreement, note, mortgage or otherwise; (iii) Release or discharge any debt due the Company unless the Company has received the
full amount thereof; or (iv) sell, mortgage, transfer or otherwise dispose of any assets of the Company.

12.3
Representation and Warranty of Executive. The Executive acknowledges and understands that the Company has extended employment
opportunities to Executive based upon Executive's representation and warranty that Executive is in good health and able to perform
the work contemplated by this Agreement for the term hereof.

12.4
Invalid Provision; Severability . The invalidity or unenforceability of a particular provision of this Agreement shall
not affect the other provisions hereof, and the Agreement shall be construed in all respects as if such invalid or unenforceable
provisions were omitted.

12.5
Entire Agreement. This Agreement contains the entire agreement and supersedes all prior agreements and understandings,
oral or written, with respect to the subject matter hereof. This Agreement may be changed only by an agreement in writing signed
by the party against whom any waiver, change, amendment, modification, or discharge is sought.

 14

 

 

    	 

    	 

    

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be

duly
executed and delivered as of the day and year first above written.

 

	 	Oncologix, Tech,
	 	 
	 	By:_______________________________________
	 	 
	 	Name: Roy Wayne Erwin
	 	 
	 	Title: Chairman and CEO

 

15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}]]